Article Text

Download PDFPDF
Isolation of peptides useful for differential diagnosis of Crohn’s disease and ulcerative colitis
  1. H Saito1,
  2. Y Fukuda2,
  3. K Katsuragi1,
  4. M Tanaka3,
  5. M Satomi2,
  6. T Shimoyama2,
  7. T Saito1,
  8. T Tachikawa1
  1. 1Department of In Vitro Diagnostics, Otsuka Life Science Initiative, Otsuka Pharmaceutical Co. Ltd, Tokushima, Japan
  2. 2Department of Internal Medicine, Division of Gastroenterology, Hyogo College of Medicine, Nishinomiya, Japan
  3. 3Medical Chemistry Research Institute, Otsuka Pharmaceutical Co. Ltd, Tokushima, Japan
  1. Correspondence to:
    H Saito, Department of In Vitro Diagnostics, Otsuka Life Science Initiative, Otsuka Pharmaceutical Co. Ltd, 463-10 Kagasuno, Kawauchi-cho, Tokushima 771- 0192, Japan;
    saitohh{at}assay.otsuka.co.jp

Abstract

Background: Phage displayed random peptide technology has been utilised to identify binding epitopes of antibodies or receptor ligands.

Aim: To isolates peptides from a phage library which are specifically recognised by antibodies in serum from patients with Crohn’s disease (CD).

Methods: A phage displayed random peptide library composed of nine amino acids was established and sequentially screened using serum immunogloblin G obtained from CD patients.

Results: Five different CD specific peptides were isolated from the phage library. No homology in amino acid sequences was observed among four (CDP-1, -3 to -5) of the five peptides exhibiting different binding characteristics with each CD patient’s serum. In contrast, two peptides (CDP-1 and -2) had similar amino acid sequences and similar binding characteristics. Four multiple antigenic peptides (MAP, CDP-1, -3 to -5) were synthesised, and an enzyme linked immunosorbent assay (ELISA) using the four peptides was developed to detect serum antibodies against them. Fifty two of 92 CD patients (56.5%) were detected by ELISA, none of 20 ulcerative colitis (UC) patients, only one of 25 duodenal ulcer patients, and only three of 48 healthy subjects.

Conclusions: ELISA using the four peptides isolated in this study may be useful for the differential diagnosis of CD and UC.

  • Crohn’s disease
  • phage displayed random peptide technology
  • inflammatory bowel disease
  • ulcerative colitis
  • serological markers
  • CD, Crohn’s disease
  • UC, ulcerative colitis
  • DU, duodenal ulcer
  • IBD, inflammatory bowel disease
  • pANCA, perinuclear antineutrophil cytoplasmic antibodies
  • ASCA, anti-Saccharomyces cerevisiae antibodies
  • ELISA, enzyme linked immunosorbent assay
  • HRP, horseradish peroxidase
  • MAP, multiple antigenic peptide
  • IPTG, isopropyl-β-d-thiogalactopyranoside
  • BSA, bovine serum albumin
  • D-PBS, Dulbecco’s phosphate buffered saline
  • LB, Luria-Bertani
  • TMB, 3,3′,5,5′-tetramethylbenzidine
  • OD, optical density
  • ROC, receiver operating characteristic

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes